FDA panel to evaluate psychedelic MDMA for treatment of PTSD for first time
byRayhan-
The U.S. Food and Drug Administration held a meeting to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder for the first time.
